Tag Archive for: Interius BioTherapeutics

Now approved in Europe: clinical trials for in vivo CAR T therapy. (Figure taken from Bui et al., in eBioMedicine 2024, CC BY NC ND 4.0, DOI: 10.1016/j.ebiom.2024.105266)
Clinical trials

First in vivo CAR gene therapy trial in Europe approved

The Paul Ehrlich Institute (PEI) has approved expansion of the global INVISE Phase 1 clinical trial to Europe. The study aims to evaluate first-in-class gene therapy for the treatment of B-cell malignancies.

Read more